Primary carnitine deficiency is a disease related to cellular mitochondria, which can be treated by taking oral carnitine to maintain the dynamic balance of carnitine in the body and prevent symptoms from worsening due to fasting and starvation. During an acute recurrence, intravenous injection of carnitine can be used to increase the body’s carnitine content, which helps in the transport and metabolism of fatty acids.

Carnitine deficiency is a disease related to mitochondrial function, where patients may need to take digestive carnitine lifelong to maintain fatty acid metabolism and prevent symptoms from worsening.